Antisense & RNAi Therapeutics Global Market Report Antisense & RNAi Therapeutics Global Market Report 2023 – By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Pulmonary Delivery, Intravenous Injections, Intradermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods), By Indication (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications) – Market Size, Trends, And Global Forecast 2023-2032 ...(expand)

Antisense therapy refers to the selective, sequence-specific suppression of gene expression by single-stranded DNA oligonucleotides. Contrarily, RNA interference (RNAi) is activated by double-stranded RNA (dsRNA) and results in the sequence-specific mRNA degradation of single-stranded target RNAs. For further insights on the antisense & RNAi therapeutics market, request a sample here

The antisense & RNAi therapeutics market growth is aided by rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases. However, some antisense & RNAi therapeutics market restraints include high cost of RNA interference-based drugs. For further insights on the antisense & RNAi therapeutics market, request a sample here

The antisense & RNAi therapeutics market is expected to reach $2.42 billion in 2027 at a rate of 12.0%. For further insights on the antisense & RNAi therapeutics market, request a sample here

The global antisense & RNAi therapeutics market is segmented as
1) By Technology: RNA Interference, Antisense RNA
2) By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
For further insights on the antisense & RNAi therapeutics market, request a sample here

North America was the largest region in the antisense & RNAi therapeutics market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the antisense & RNAi therapeutics market are, Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, Quark Pharmaceuticals, Sanofi S.A, Acuitas Therapeutics, Antisense Therapeutics Ltd., Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals), Bio-Path Holdings Inc., Calando Pharmaceuticals, Dicerna Pharmaceuticals, Enzon Pharmaceuticals Inc, Gradalis, iCo Therapeutics, miRagen Therapeutics, Olix Pharmaceuticals, OncoGeneX Pharmaceuticals, Lorus Therapeutics (Aptose Biosciences), Regulus Therapeutics, Rexahn Pharmaceuticals, Rxi Pharmaceuticals, Santaris Pharma A/S (Roche), Sarepta Therapeutics, Silence Therapeutics Plc, Sirnaomics Inc., Tekmira Pharmaceuticals, Cenix BioScience, Sirnaomics. For further insights on the antisense & RNAi therapeutics market, request a sample here.

Major trends influencing the antisense & RNAi therapeutics market include undertaking strategic initiatives such as collaborations and partnerships for product innovation to sustain in the increasingly competitive market. Companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated as well as with academic and research institutions in this market by way of partnerships, and in or out-licensing deals. This trend has been increasing over recent years. For further insights on the antisense & RNAi therapeutics market, request a sample here.

For detailed insights on the major opportunities and strategies in the antisense & RNAi therapeutics market, request a sample here.

For detailed insights on antisense & RNAi therapeutics market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the antisense & RNAi therapeutics industry, request a sample here.

For detailed insights on the key dynamics influencing the antisense & RNAi therapeutics market growth and SWOT analysis of the antisense & RNAi therapeutics industry, request a sample here.